BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

Xtant Medical (XTNT)Xtant MedicalEarnings

BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the second quarter ended June 30,

Related news

HYPRHyperfine2026-07-23 20:05 EST

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

ATRCAtriCure2026-07-02 12:00 EST

AtriCure to Announce Second Quarter 2026 Financial Results

ICUSeaStar Medical2026-08-06 12:35 EST

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

IRIXIRIDEX2026-08-04 20:05 EST

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

CVRXCVRx2026-07-23 20:30 EST

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

APYXApyx Medical2026-07-23 12:00 EST

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

SGHTSight Sciences2026-07-22 20:05 EST

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

View all latest news

Xtant Medical

Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures. Biologics and Implants The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments. Hemostasis Expansion An exclusive U.S. distribution agreement...

Recent company news

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Stock data

Close
0.44 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States